Omkar Pharmachem Ltd vs Prima Innovation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Omkar Pharmachem Ltd is ₹ 7.23 as of 23 Oct 15:30 . The P/E Ratio of Omkar Pharmachem Ltd changed from 113.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Prima Innovation Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Omkar Pharmachem Ltd changed from ₹ 20.57 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Prima Innovation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Omkar Pharmachem Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.09 crore. This represent the decline of 0% The revenue of Prima Innovation Ltd for the Jun '26 is ₹ 15.32 crore as compare to the Mar '26 revenue of ₹ 14.44 crore. This represent the growth of 6.09% The ebitda of Omkar Pharmachem Ltd for the Jun '26 is ₹ -0.01 crore as compare to the Mar '26 ebitda of ₹ 0.02 crore. This represent the decline of -150% The ebitda of Prima Innovation Ltd for the Jun '26 is ₹ 1.65 crore as compare to the Mar '26 ebitda of ₹ 1.47 crore. This represent the growth of 12.24% The net profit of Omkar Pharmachem Ltd changed from ₹ 0.05 crore to ₹ -0.01 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Prima Innovation Ltd changed from ₹ -0.55 crore to ₹ 0.46 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Omkar Pharmachem Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prima Innovation Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Omkar Pharmachem Ltd

Omkar Pharmachem Limited was incorporated on March 31, 1995.
The Company has not done any commercial activity during the year.
At present, it is incorporated with the object of doing business of pharmaceuticals and chemical product in 2017-18. The main objects of the Company are related to pharmaceuticals, chemicals and to provide Management and business support services.
Currently, Company is engaged in business of providing support services related activities.

FAQs for the comparison of Omkar Pharmachem Ltd and Prima Innovation Ltd

Which company has a larger market capitalization, Omkar Pharmachem Ltd or Prima Innovation Ltd?

Market cap of Omkar Pharmachem Ltd is 7 Cr while Market cap of Prima Innovation Ltd is 28 Cr

What are the key factors driving the stock performance of Omkar Pharmachem Ltd and Prima Innovation Ltd?

The stock performance of Omkar Pharmachem Ltd and Prima Innovation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Omkar Pharmachem Ltd and Prima Innovation Ltd?

As of October 24, 2026, the Omkar Pharmachem Ltd stock price is INR ₹7.23. On the other hand, Prima Innovation Ltd stock price is INR ₹25.53.

How do dividend payouts of Omkar Pharmachem Ltd and Prima Innovation Ltd compare?

To compare the dividend payouts of Omkar Pharmachem Ltd and Prima Innovation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.